The harsh realities facing the use of SPECT imaging in monitoring disease progression in Parkinson's disease [4] (multiple letters)

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 74, Issue 10, 2003, Pages 1447-

  Morrish, P K ^a   Winogrodzko, A ^b   Booij, J ^b   Wolters, E Ch ^b  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MONITORING; BRAIN RADIOGRAPHY; DISEASE COURSE; HUMAN; LETTER; NEUROPROTECTION; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIPARKINSON AGENTS; CLINICAL TRIALS; DISEASE PROGRESSION; ENDPOINT DETERMINATION; HUMANS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0346997025     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.10.1447     Document Type: Letter

References (0)